Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Announces $5 Million Share Repurchase Program
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
Last Price
$
52-Week Range
$ - $
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808